Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Astrana Health Inc. (ASTH)
:ASTH
Holding ASTH?
Track your performance easily
ASTH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$29.08 - $63.20
Previous CloseN/A
Volume92.25K
Average Volume (3M)341.93K
Market Cap
$1.64B
Enterprise Value$2.72B
Total Cash (Recent Filing)$8.66M
Total Debt (Recent Filing)$5.00M
Price to Earnings (P/E)27.0
Beta1.32
Next Earnings
Feb 20, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.30
Shares Outstanding49,120,033
10 Day Avg. Volume417,512
30 Day Avg. Volume341,925
Standard Deviation0.20
R-Squared0.10
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.09
Price to Cash Flow (P/CF)13.80
P/FCF Ratio14.80
Enterprise Value/Market Cap1.66
Enterprise Value/Revenue1.58
Enterprise Value/Gross Profit12.66
Enterprise Value/Ebitda20.73
Forecast
1Y Price Target
$60.63Price Target Upside81.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Astrana Health News
PremiumCompany Announcements
Astrana Health Updates Corporate Presentation Amid Acquisition
PremiumCompany Announcements
Astrana Health to Share Financial Insights at Conferences
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyThe surprise coming out of Q3 was not the results, but the agreement to acquire Prospect’s Medical Group for $745m, which hardens CA positioning and provides upside to numbers.
Competitive AdvantageDistinct competitive advantages include extensive capitation risk-taking experience, superior clinical outcomes powered by a proprietary technology platform, and flexible risk models.
Growth And ProfitabilityThe company was able to 5x the profitability from $7m in EBITDA to $35m in less than 5 years by moving more patients further into value-based care, indicating successful integration and operational improvements.
Bears Say
Financial PerformanceASTH's current reporting disclosures lack details to fully assess the quarterly performance of each service line.
Market ExpansionExpansion into new markets and large acquisitions create margin headwind amidst industry-wide challenges.
Operational ChallengesManagement acknowledged that exporting VBC models into new geographies is difficult as it requires significant scale to get leverage on fixed cost investments.
---
Ownership Overview
39.46% Insiders
16.99% Mutual Funds
1.18% Other Institutional Investors
19.83% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $29.08 and its highest was $63.20 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $1.64B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Feb 20, 2025 which is in 33 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on Nov 07, 2024. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.309 by $0.021.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.1.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 49,120,033 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.33 in its last earnings report, beating expectations of $0.309. Following the earnings report the stock price went down -20.515%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
---
Astrana Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$60.63 (81.74% Upside)
$60.63 (81.74% Upside)
Hedge Fund Trend
Increased
By 203.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.5%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.59%
12-Months-Change
Fundamentals
Return on Equity
9.62%
Trailing 12-Months
Asset Growth
19.76%
Trailing 12-Months
Company Description
Astrana Health Inc.
Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient, and physician alignment solutions. The company focuses on physicians providing medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The firm operates through the healthcare delivery segment. The healthcare delivery segment implements and operates innovative health care models to create a patient-centered, physician-centric experience. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.
---
ASTH Company Deck
---
ASTH Earnings Call
Q3 2024
0:00 / 0:00
---
ASTH Stock 12 Month Forecast
Average Price Target
$60.63
▲(81.74% Upside)
Technical Analysis
Best Analysts Covering ASTH
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
+7.27%
reiterated a buy rating 4 months ago
Copying David Larsen's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +7.27% per trade.
---